Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

Related Posts

Collaboration with DuPont Water Solutions to Test Lithium...

April 17, 2025

WGC: Central Banks, Investors Fuel Record 2024 Gold...

February 11, 2025

Uranium Stocks: 5 Biggest Companies in 2025

May 20, 2025

Appointment of Chief Executive Officer

January 13, 2025

Crypto Market Recap: Volatility Heats Up Midweek

February 6, 2025

SAGA Metals Completes Petrographic Analysis at Drill Ready...

January 20, 2025

RUA GOLD Expands High-Grade Intercepts at Depth at...

April 17, 2025

Lodgement of CONNEQT Pulse Device with the TGA

May 6, 2025

First patient dosed in Phase IIb imaging for...

April 28, 2025

5 US Longevity and Anti-aging Stocks to Watch...

January 24, 2025

Recent Posts

  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips
  • Applying Key Ratios to the Broader Market Surge: Are We at the Threshold of a New Trend?
  • Moving from Thrust Signals to a Bull Market
  • What Happens When the S&P 500 Breaks Below Gap Support?
  • Automate Your Scans with Ease! Sample Scan Library + Scheduled Scans Walkthrough

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips

    May 24, 2025

  • Applying Key Ratios to the Broader Market Surge: Are We at the Threshold of a New Trend?

    May 24, 2025

  • Moving from Thrust Signals to a Bull Market

    May 24, 2025

  • What Happens When the S&P 500 Breaks Below Gap Support?

    May 24, 2025

  • Automate Your Scans with Ease! Sample Scan Library + Scheduled Scans Walkthrough

    May 24, 2025

  • 3 Stocks to Watch While Everyone’s Staring at NVIDIA

    May 24, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (368)
  • Investing (1,188)
  • Politics (1,482)
  • Stocks (485)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved